SCHEMBL13603003

SCHEMBL13603003

COC(=O)c1cc(N)c(Cl)c2c1OCCO2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.55
ALDH1A1 P00352 6/20 0.55
ABL1 P00519 1/20 0.46
GAA P10253 5/20 0.44
NQO2 P16083 3/20 0.43
HTR4 Q13639 2/20 0.41
HSD17B10 Q99714 4/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
GLA P06280 2/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ATM Q13315 1/20 0.41
CFTR P13569 3/20 0.40
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
LMNA P02545 2/20 0.38
HTR2C P28335 2/20 0.37
HTR3A P46098 2/20 0.37
HTR3E A5X5Y0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7398883 0.84 KDM4E (0.58) KDM4EALDH1A1ABL1GAANQO2
SCHEMBL14810489 0.82 HTR4 (0.58) KDM4EALDH1A1ABL1GAANQO2
SCHEMBL19723019 0.81 KDM4E (0.43) KDM4EALDH1A1ABL1GAAHTR4
SCHEMBL15323760 0.81 KDM4E (0.54) KDM4EALDH1A1ABL1GAAHTR4
SCHEMBL13315460 0.79 ALDH1A1 (0.41) KDM4EALDH1A1ABL1GAANQO2
SCHEMBL15324655 0.77 KDM4E (0.50) KDM4EALDH1A1ABL1GAAHTR4
SCHEMBL13385019 0.77 PDGFRB (0.43) KDM4EALDH1A1HTR4MAPTLMNA
SCHEMBL30507871 0.77 KDM4E (0.53) KDM4EALDH1A1ABL1GAAHTR4
SCHEMBL29054678 0.77 KDM4E (0.53) KDM4EALDH1A1ABL1GAAHTR4
SCHEMBL7402316 0.76 ALDH1A1 (0.55) KDM4EALDH1A1ABL1GAAHTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638535-B2 (3S)-trans)-8-methyl-3,4-dihydro-2H-benzo[b][1,4]dioxepine-6-carboxylic acid [3-hydroxy-1-(3-methoxy-propyl)-piperidin-4-ylmethyl]-amide; hypermotility, irritable bowel syndrome, constipation or diarrhea predominant IDS, pain and non-pain predominant IBS and bowel hypersensitivity JANSSEN PHARMACEUTICA N.V. (BE) 2009-12-29 US disclosed
US-7638535-B2 (3S)-trans)-8-methyl-3,4-dihydro-2H-benzo[b][1,4]dioxepine-6-carboxylic acid [3-hydroxy-1-(3-methoxy-propyl)-piperidin-4-ylmethyl]-amide; hypermotility, irritable bowel syndrome, constipation or diarrhea predominant IDS, pain and non-pain predominant IBS and bowel hypersensitivity JANSSEN PHARMACEUTICA N.V. (BE) 2009-12-29 US disclosed